Panic Disorder: Symptoms, Causes, Treatment & Nursing Care

Panic disorder sits within the family of conditions summarised internationally as anxiety disorders: episodic surges of fear drive sympathetic activation—tachycardia, sweat, tremor, air hunger, light-headedness—often paired with catastrophic cognitions (“I am dying,” “I will collapse”). While isolated panic attacks occur across psychiatric and medical contexts, panic disorder specifically implies repeated unexpected attacks plus clinically significant anticipatory anxiety or behavioural avoidance afterward. Fear-conditioning models explain how interoceptive cues (skipped beats, gastric sensations) become triggers once catastrophic interpretations consolidate.

Nursing relevance lies in translating neurobiology into ward cues: hyperventilation lowers CO₂, provoking dizziness and perioral tingling that fuel further panic; stimulant use (prescribed or caffeine excess), sleep deprivation, and postpartum physiology lower the symptom threshold. Frame panic disorder as treatable—combined psychotherapy and pharmacotherapy yields meaningful response when pathways maintain dose, adherence coaching, and exposure homework rather than perpetual rescue sedation.

APA DSM-5 criteria operationalise panic disorder as recurrent panic attacks with ≥1 month of worry about additional attacks or maladaptive change (avoidance, safety behaviours). Panic attacks themselves require an abrupt surge reaching peak intensity within minutes, with ≥4 somatic or cognitive symptoms from the canonical list (APA anxiety overview). Unexpected (“uncued”) attacks differentiate panic disorder from situationally bound panic seen in specific phobia.

↔On a small screen, swipe or scroll sideways to see the full table.

Validated measures (PDSS, ACQ, BSQ in specialist services; GAD-7/PHQ-9 in primary care for comorbidity) help track severity when staff are trained—scores support but never replace suicide and medical safety screening.

Patients describe abrupt waves of doom with pounding pulse, sweat, tremulous hands, lump-in-throat choking, air hunger (shortness of breath), abdominal distress, heat or chill flushes, and depersonalisation. Many seek care through cardiology or ED first because chest pain dominates the narrative—after exclusion, clinicians should still validate physiologic intensity while steering toward CBT and graded exposure rather than implying fabrication.

Who presents atypically

• Older adults: emphasise cardiac and pulmonary mimics; depression overlap may mute subjective fear yet preserve somatic intensity.
• People with stigma-heavy backgrounds: somatic metaphors replace “panic”—probe function (“Can you ride the bus alone?”).
• Postpartum individuals: sleep fragmentation plus hormonal shifts inflate panic incidence—coordinate obstetric teams when meds are contemplated.

Familial clustering and twin studies imply genetic susceptibility interacting with smoking, childhood adversity, and life stress (NIMH publication). Noradrenergic and serotonergic dysregulation models inform pharmacotherapy targets, while learning theory explains persistent avoidance once safety behaviours (escape, companion-only travel) entrench.

Modifiable contributors

• Excess caffeine or energy drinks, nicotine, recreational stimulants.
• Sleep deprivation from shift work—relevant to nursing colleagues seeking help.
• Alcohol binge–withdrawal cycles lowering GABA tone between episodes.

Clinical assessment

Map attack frequency, situational triggers versus spontaneous onset, avoidance breadth, trauma cues (post-traumatic stress disorder), manic switches suggesting bipolar disorder, and substance timelines. Ask occupation impacts—lost shifts, avoidance of elevators in hospitals—and driving restrictions.

Laboratory investigations

• TSH ± thyroid panels when thyrotoxicosis suspected; overlap with tremor and palpitations.
• ECG if symptoms suggest rhythm disturbance or ACS risk factors.
• Pregnancy test when reproductive status unclear before starting serotonergic drugs; glucose or metabolic screen if comorbid diabetes.

Imaging

Not routine for panic disorder—reserve for focal neuro signs or atypical cardiopulmonary findings per specialist.

Criteria and screening context

US primary care increasingly embeds anxiety disorder screening tools for adults younger than 65 when diagnostic and care pathways exist (USPSTF anxiety screening statement). Positive screens warrant clinical interview—not automatic labelling.

↔On a small screen, swipe or scroll sideways to see the full table.

UK NICE CG113 outlines stepped care: education, active monitoring, low-intensity guided self-help, then high-intensity CBT (including exposure) or drug treatment, with combinations and specialist referral for refractory complexity (NICE CG113). NHS materials stress CBT skill acquisition and gradual re-engagement with avoided situations (NHS panic disorder).

First-line psychotherapy

• CBT targeting catastrophic misinterpretations, interoceptive exposure, and reduction of subtle safety behaviours.
• Applied relaxation (where trained therapists available) per NICE options for panic disorder.

First-line pharmacotherapy (prescriber-led)

• SSRIs: sertraline, escitalopram; monitor activation, GI upset, sexual dysfunction.
• SNRI: venlafaxine when SSRI inadequate—check blood pressure.
• Explain delayed onset (commonly weeks) so patients do not abandon therapy prematurely (NHS timelines).

Adjunctive physical symptom tools

• Situational performance anxiety may use beta-adrenergic blockade—see overview of propranolol with asthma/heart-block cautions.

Second-line / cautionary medicines

• Benzodiazepines only short, goal-directed courses with dependence education per WHO.
• Pregabalin appears in some national pathways—dependence and sedation counselling remain mandatory.

Special populations

• Pregnancy/lactation: involve perinatal psychiatry—balance maternal functioning against neonatal considerations.
• Older adults: start low, go slow; monitor sodium, falls, interactions.
• Adolescents: family involvement for exposures; suicide vigil after antidepressant adjustments.

• Follow-up cadence: nursing contacts ~1–2 weeks after SSRI initiation or dose change to screen activation, insomnia shifts, bleeding risk discussion if anticoagulated, hyponatraemia symptoms in older adults, and suicidal ideation.
• Treatment failure triggers: continued frequent ED visits despite therapy, inability to leave home, worsening depression, or intolerance—escalate to psychology/psychiatry MDT.
• Exposure adherence: homework compliance predicts outcomes—document psychoeducation reinforcement each visit.
• Care coordination: fax or portal summaries to ED clinicians reduce contradictory messaging between “everything normal” labs and untreated panic disorder.
• Referral thresholds: severe agoraphobia, recurrent self-harm urges, suspected bipolar switch, eating-disorder comorbidity with electrolyte risk.

Bedside monitoring checklist

• Vital signs including SpO₂ when dyspnoea dominates; capnometry or guided breathing after hyperventilation stabilisation in controlled settings.
• Orthostatic blood pressure after PRN sedation or dehydration from vomiting.
• Medication reconciliation for serotonergic stacking, QT-prolonging combinations, opioid coprescribing.
• Suicide screening after every high-intensity surge or therapy setback.

• Housebound agoraphobia with nutritional and deconditioning risk.
• Major depression from chronic limitation and shame.
• Alcohol misuse as self-medication—worsens sleep architecture and withdrawal panic.
• Iatrogenic harm from chronic benzodiazepines: falls, cognitive fog, withdrawal seizures if stopped abruptly.

Where systems allow, combine population-level anxiety literacy (CDC mental health data pages highlighting undertreatment gaps) with early CBT access for prodromal avoidance. Workplace education for healthcare students may reduce catastrophic interpretation of benign palpitations during shift stress. Smoking cessation and caffeine moderation lower autonomic volatility in genetically vulnerable individuals.

With structured CBT and/or SSRI/SNRI treatment, many patients achieve durable remission, though setbacks follow life stress or medication discontinuation. Relapse-prevention booster sessions and gradual SSRI tapers supervised by prescribers outperform abrupt stops that mimic panic resurgence or withdrawal symptoms.

Therapeutic communication

Name the physiology (“sympathetic surge”) without ridicule; distinguish panic attack intensity from character weakness. Coach slow-breathing only after ACS cleared—hyperventilation education must not delay red-flag workups when presentation is ambiguous.

Medication administration

Confirm patients know morning vs evening SSRI timing, avoid double-dosing after missed pills, and understand that benzodiazepines are not benign “extras.” Teach opioid interaction alerts when sedatives coexist.

Documentation

Record prodrome, interventions offered, collateral from companions, referral bookings, and crisis-line instructions—especially after ED discharge for chest pain deemed non-cardiac.

Align psychiatric crises with regional equivalents of 988 in the United States or local urgent mental-health lines elsewhere.

These NCLEX-style clinical judgment practice items focus on the nursing priorities for this condition — recognise cues, escalate red flags, take safe action and evaluate outcomes (NCSBN Clinical Judgment Measurement Model) — through Priority FIRST, SATA, deterioration trends, multi-patient triage, ordered response, matrix matching and cloze tasks on the topic of panic disorder—unexpected panic attacks, CBT/exposure sequencing, SSRI initiation counselling, benzodiazepine hazards, cardiac mimic triage, and suicidality within the Clinical Judgment Measurement Model layers for recognizing cues and taking safe actions.